Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $27.1700 (-3%) ($27.1700 - $27.9900) on Tue. Jul. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.36% (three month average) | RSI | 43 | Latest Price | $27.1700(-3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.8% a day on average for past five trading days. | Weekly Trend | HALO declines -1.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(47%) IWC(44%) ARKG(42%) | Factors Impacting HALO price | HALO will decline at least -1.18% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-2%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.18% (StdDev 2.36%) | Hourly BBV | 0 () | Intraday Trend | -2.9% | | | |
|
Resistance Level | $27.95 | 5 Day Moving Average | $27.47(-1.09%) | 10 Day Moving Average | $28.02(-3.03%) | 20 Day Moving Average | $27.95(-2.79%) | To recent high | -6.4% | To recent low | 19.9% | Market Cap | $3.713b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |